DCP Logo
  • Home
  • About
    • DCP program
    • DCP program history
    • Structural Genomic Consortium
    • Probe contributions
  • Show Probes
    • All
    • Kinase
    • GPCR
    • Ion channel
    • Epigenetics
    • Other enzymes
    • Other targets
  • Order set
  • Download
  • Information
    • FAQ
    • Probe resources
    • Donate probes
    • Contact
    • Funding
    • Update history
All probes Probe criteria Further information Usage Order Properties Structure Compound analysis Potency Selectivity Data download
  • Probe criteria
  • Further information
  • Usage
  • Order
  • Properties
  • Structure
  • Compound analysis
  • Potency
  • Selectivity
  • Data download

Potency data for probe GSK778


In vitro potency


Target name Target information Species Assay description GSK778 Publication of assay conditions
BRD2 BD1 Homo sapiens TR-FRET assay (BRD2 BD1) IC50 = 75 nM ± 4.000 nM (n=6) PMID: 32193360
BRD2 BD2 Homo sapiens TR-FRET assay (BRD2 BD2) IC50 = 3950 nM ± 290.000 nM (n=8) PMID: 32193360
BRD3 BD1 Homo sapiens TR-FRET assay (BRD3 BD1) IC50 = 41 nM ± 5.000 nM (n=6) PMID: 32193360
BRD3 BD2 Homo sapiens TR-FRET assay (BRD3 BD2) IC50 = 1210 nM ± 65.000 nM (n=6) PMID: 32193360
BRD4 BD1 Homo sapiens TR-FRET assay (BRD4 BD1) IC50 = 41 nM ± 3.000 nM (n=16) PMID: 32193360
BRD4 BD2 Homo sapiens TR-FRET assay (BRD4 BD2) IC50 = 5843 nM ± 304.000 nM (n=16) PMID: 32193360
BRDT BD1 Homo sapiens TR-FRET assay (BRDT BD1) IC50 = 143 nM ± 14.000 nM (n=6) PMID: 32193360
BRDT BD2 Homo sapiens TR-FRET assay (BRDT BD2) IC50 = 17451 nM ± 1938.000 nM (n=6) PMID: 32193360
BRD2 BD1 Homo sapiens BET mutant TR-FRET assay (BRD2 BD1) pIC50 = 7.1 ± 0.060 (n=8) PMID: 32787145
BRD2 BD2 Homo sapiens BET mutant TR-FRET assay (BRD2 BD2) pIC50 = 5.5 ± 0.260 (n=10) PMID: 32787145
BRD3 BD1 Homo sapiens BET mutant TR-FRETassay (BRD3 BD1) pIC50 = 7.4 ± 0.090 (n=8) PMID: 32787145
BRD3 BD2 Homo sapiens BET mutant TR-FRET assay (BRD3 BD2) pIC50 = 6 ± 0.170 (n=8) PMID: 32787145
BRD4 BD1 Homo sapiens BET mutant TR-FRET assay (BRD4 BD1) pIC50 = 7.4 ± 0.150 (n=16) PMID: 32787145
BRD4 BD2 Homo sapiens BET mutant TR-FRET assay (BRD4 BD2) pIC50 = 5.2 ± 0.090 (n=16) PMID: 32787145
BRDT BD1 Homo sapiens BET mutant TR-FRET assay (BRDT BD1) pIC50 = 6.8 ± 0.090 (n=8) PMID: 32787145
BRDT BD2 Homo sapiens BET mutant TR-FRET assay (BRDT BD2) pIC50 = 4.8 ± 0.130 (n=8) PMID: 32787145
BRD2 BD1 Homo sapiens BRD2 Bromoscan (DiscoverX) Kd = 13 nM PMID: 32787145
BRD3 BD1 Homo sapiens BRD3 Bromoscan (DiscoverX) Kd = 5 nM PMID: 32787145
BRD4 BD1 Homo sapiens BRD4 Bromoscan (DiscoverX) Kd = 5.9 nM PMID: 32787145
BRDT BD1 Homo sapiens BRDT Bromoscan (DiscoverX) Kd = 18 nM PMID: 32787145
BRD4 BD1 Homo sapiens BRD4 BD1 SPR pKd = 8 PMID: 32787145
BRD4 BD2 Homo sapiens BRD4 BD2 SPR pKd = 5.9 PMID: 32787145


In cell potency


Target name Target information Species Assay description GSK778 Publication of assay conditions
HEK293 cells Homo sapiens NanoBRET pIC50 = 7.3 PMID: 32787145
AML cell line MV-4−11 with MLL-AF4 rearrangement Homo sapiens Cell proliferation assay: Growth inhibition after 3 days pIC50 = 7 PMID: 32787145